Frequency Therapeutics Completes Enrollment of Phase 2b …
https://hearinghealthmatters.org/hearing-news-watch/2022/frequency-therapeutics-phase2b-clinical-trial/
WebOctober 12, 2022. LEXINGTON, MASSACHUSSETTS — Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced that it has completed enrollment of its placebo-controlled Phase 2b study of FX-322 in ...
DA: 96 PA: 18 MOZ Rank: 66